The results showed that CAND1 mRNA expression was upregulated in breast cancer patients compared to tumor-adjacent and normal breast tissue and that CAND1 expression was upregulated in ERα-positive breast cancer compared to ERα-negative breast cancer, suggesting that CAND1 might predict prognosis in ERα-positive breast cancer. This evidence concerns the gene CAND1 and breast carcinoma.